AKAM
64
2
WAT
49
2
PCG
74
2
ORCL
33
7
ADT
50
2
KSS
62
3
ALL
56
2
HPE
75
7
PWR
56
3
PFE
33
-8
VTR
67
-3
PH
62
2
ADP
54
-4
IR
58
3
INTC
43
6
NOC
54
6
CMCSA
44
-2
SYY
45
-3
STT
62
3
EMN
56
-2
AKAM
64
2
WAT
49
2
PCG
74
2
ORCL
33
7
ADT
50
2
KSS
62
3
ALL
56
2
HPE
75
7
PWR
56
3
PFE
33
-8
VTR
67
-3
PH
62
2
ADP
54
-4
IR
58
3
INTC
43
6
NOC
54
6
CMCSA
44
-2
SYY
45
-3
STT
62
3
EMN
56
-2
Financhill
Back

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
42

VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF

Last Price:
$83.64
Seasonality Move:
-0.39%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
42
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT) is a Sell

Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $83.64. The Score for VCIT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • VCIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCIT Stock Price Chart

What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?

  • The Vanguard Intermediate-Term Corp Bond Idx Fund ETF share price today is $83.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCIT is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

VCIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.74 Buy
Relative Strength Index (14 RSI): 42.6 Sell
Chaikin Money Flow: -5608064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.64 - 84.22) Sell
Bollinger Bands (100): (83.31 - 84.37) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

VCIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.84 Sell
20-day SMA: 84.01 Sell
50-day SMA: 84.07 Sell
200-day SMA: 82.66 Buy
8-day EMA: 44.34 Buy
20-day EMA: 21.72 Buy
50-day EMA: 9.47 Buy
200-day EMA: 2.48 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):